Nafcillin Inj Rx
Generic Name and Formulations:
Nafcillin sodium 1g/vial, 2g/vial, 10g/vial; pwd for deep IM inj after reconstitution, IV inj or IV drip after reconstitution and dilution.
Various generic manufacturers
Indications for Nafcillin Inj:
Susceptible infections due to penicillinase-producing staphylococci.
Give by deep IM gluteal inj, or IV inj over 5–10 mins, or short-term IV drip for 24–48 hours. IM: 500mg every 4–6 hours. IV: 500mg every 4 hours. Severe infections: 1g IM or IV every 4 hours; treat for at least 14 days, then continue for at least 48 hours after becoming afebrile, asymptomatic, or (–) cultures. Endocarditis or osteomyelitis: may need longer therapy; see literature. Switch to oral therapy as soon as clinically indicated.
Give by deep IM gluteal inj only. Neonates: 10mg/kg twice daily. Infants and children <40kg: 25mg/kg twice daily.
Cephalosporin or other allergy: not recommended. Asthma. Renal impairment: consider dose reduction. Do CBCs, BUN, urinalysis, creatinine levels prior to and weekly during therapy. Monitor renal, hepatic and hematopoietic function in prolonged use. Elderly (esp. IV route). Newborns (monitor). Pregnancy (Cat.B). Nursing mothers.
May be antagonized by tetracycline; avoid. Potentiated by probenecid.
Inj site reactions, rash, serum sickness, GI upset, anaphylaxis, neuropathy, nephropathy, blood dyscrasias.
Formerly known under the brand names Nallpen, Unipen.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- Higher Radiation Dose May Not Improve Prostate Cancer Outcomes
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches